(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 th and June 3 rd, 2025, was host to a biomarkers in kidney cancer session. Dr.

(EBC) patients receiving Kisqali in 1-year post-treatment analysis1Tolerability remained consistent, with fewer treatment discontinuations due to adverse events among pre-menopausal patients1Rising br ...

In the phase 3 PANOVA-3 trial, patients who underwent tumor-treating fields therapy had extended overall survival vs standard ...

The beloved comedian reacted to the outpouring of well wishes days after she was forced to respond to online trolls.

This week, beloved Australian comedian Magda Szubanski shared she is battling a "rare and fast-moving blood cancer". The ...

Magda Szubanski has taken to social media again after a flood of responses to her revelation of a devastating cancer ...

Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.